Proximal and distal gut hormone secretion in slow transit constipation

European Journal of Clinical Investigation

Volumn 30, Issue 8, 2000, Pages 709-714

  Penning, C ^a   Delemarre, J B V M ^a   Bemelman, W A ^a   Biemond, I ^a   Lamers, C B H W ^a   Masclee, A A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastrointestinal hormones; Oro caecal transit time; Slow transit constipation

Indexed keywords

CHOLECYSTOKININ; GASTRIN; GASTROINTESTINAL HORMONE; MOTILIN; NEUROTENSIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

ADULT; AGED; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GASTRIN BLOOD LEVEL; GASTROINTESTINAL MOTILITY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROGEN BREATH TEST; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; CONSTIPATION; DIGESTIVE SYSTEM; FASTING; FEMALE; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRANSIT; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0033854149     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00692.x     Document Type: Article

References (33)

1. 1 Halligan S, Bartram CI. The radiological investigation of constipation (review). Clin Radiol 1995;50:429-35.
2. 2 Piccirillo MF, Reissman P, Wexner SD. Colectomy as treatment for constipation. Gastroenterology 1996;110:1666-71.
3. 3 Kamm MA, Hawley PR, Lennard-Jones JE. Outcome of colectomy for severe idiopathic constipation. Gut 1988;29:969-73.
4. 4 Redmond JM, Smith GW, Barofsky I, Ratych RE, Goldsborough DC, Schuster MM. Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol 1995;90:748-53.
5. 5 Reynolds JC, Ouyang A, Lee CA, Baker L, Sunshine AG, Cohen S. Chronic severe constipation: prospective motility studies in 25 consecutive patients. Gastroenterology 1987;92:414-20.
6. 6 van der Sijp JRM, Kamm MA, Nightingale JMD, Britton KE, Granowska M, Mather SJ et al. Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci 1993;38:837-44.
7. 7 Bassotti G, Stanghellini V, Chiaroni G, Germani U, De Giorgio R, Vantini I et al. Upper gastrointestinal motor activity in patients with slow-transit constipation: further evidence for an enteric neuropathy. Dig Dis Sci 1996;41:1999-2005.
8. 8 Panagamuwa B, Kumar D, Ortiz J, Keighley MRB. Motor abnormalities in the terminal ileum of patients with chronic idiopathic constipation. Br J Surg 1994;81:1685-8.
9. 9 Penning C, Gielkens HAJ, Hemelaar M, Delemarre JBVM, Lamers CBHW, Masclee AAM. Prolonged ambulatory recording of antroduodenal motility in slow transit constipation. Br J Surg 2000;87:211-17.
10. 10 van der Sijp JRM, Kamm MA, Nightingale JM, Akkermans LM, Ghatei MA, Bloom SR et al. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation. Am J Gastroenterol 1998;93:1351-6.
11. 11 Mollen RMHG, Hopman WPM, Kuijpers JHC, Jansen JBMJ. Abnormalities of plasma cholecystokinin and peptide YY in patients with slow transit constipation. Gastroenterology 1997;112:A792 (Abstract).
12. 12 Preston DM, Adrian TE, Christofides ND, Lennard-Jones JE, Bloom SR. Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. Gut 1985;26:1059-64.
13. 13 Jorge JMN, Wexner SD, Ehrenpreis ED. The lactulose hydrogen breath test as a measure of orocaecal transit time. Eur J Surg 1994;160:409-16.
14. 14 Marzio L, Del Bianco R, Delle Donne M, Pieramico O, Cuccurullo F. Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan. Am J Gastroemerol 1989;84:888-91.
15. 15 Wald A. Colonic transit and anorectal manometry in chronic idiopathic constipation. Arch Intern Med 1986;146:1713-16.
16. 16 Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983;131:305-16.
17. 17 Jansen JBMJ, Lamers CBHW. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 1982;83:173-8.
18. 18 Lamers CBHW, Diemel CM, van Leer E, van Leusen R, Peetoom JJ. Mechanism of elevated serum pancreatic polypeptide concentrations in chronic renal failure. J Clin Endocrinol Metab 1982;55:922-6.
19. 2) measurements. J Lab Clin Med 1975;85:546-55.
20. 20 Luiking YC, Peeters TL, Stolk MF, Nieuwenhuijs VB, Portincasa P, Depoortere I et al. Motilin induces gall bladder emptying and antral contractions in the fasted state in humans. Gut 1998;42:830-5.
21. 21 Peracchi M, Basilisco G, Tagliabue R, Terrani C, Locati A, Bianchi PA et al. Postprandial gut peptide plasma levels in women with idiopathic slow-transit constipation. Scand J Gastroenterol 1999;34:25-8.
22. 22 Sjȯlund K, Ekman R, Akre F, Lindner P. Motilin in chronic idiopathic constipation. Scand J Gastroenterol 1986;21:914-18.
23. 23 Penning C, Gielkens HAJ, Delemarre JBVM, Lamers CBHW, Masclee AAM. Gallbladder motility in severe idiopathic constipation. Gut 1999;45:264-8.
24. 24 Fried GM, Ogden WD, Greeley GH Jr, Thompson JC. Physiologic role of cholecystokinin in the intestinal phase of pancreatic polypeptide release. Ann Surg 1984;200:600-4.
25. 25 Huge A, Weber E, Ehrlein HJ. Effects of enteral feedback inhibition on motility, luminal flow, and absorption of nutrients in proximal gut of minipigs. Dig Dis Sci 1995;40:1024-34.
26. 26 Eisenbraun J, Ehrlein HJ. Effects of somatostatin on luminal transit and absorption of nutrients in the proximal gut of minipigs. Dig Dis Sci 1996;41:894-901.
27. 27 Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985;89:1070-7.
28. 28 Masclee AAM, Hopman WPM, Corstens FH, Rosenbusch G, Jansen JBMJ, Lamers CBHW. Simultaneous measurement of gallbladder emptying with cholescintigraphy and US during infusion of physiologic doses of cholecystokinin: a comparison. Radiology 1989;173:407-10.
29. 29 Straathof JWA, Mearadji B, Lamers CBHW, Masclee AAM. Effect of CCK on proximal gastric motor function in humans. Am J Physiol 1998;274:G939-G944.
30. 30 Lieverse RJ, Jansen JBMJ, Masclee AAM, Lamers CBHW. Satiety effects of a physiological dose of cholecystokinin in humans. Gut 1995;36:176-9.
31. 31 Kleibeuker JH, Beekhuis H, Jansen JBMJ, Piers DA, Lamers CBHW. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man. Eur J Clin Invest 1988;18:173-7.
32. 32 Niederau C, Karaus M. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs. Am J Physiol 1991;260:G315-G324.
33. 33 Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986;90:379-84.